Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) COO Michael Willem Waters sold 4,218 shares of Teladoc Health stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $30,200.88. Following the completion of the sale, the chief operating officer now owns 78,309 shares of the company’s stock, valued at $560,692.44. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Michael Willem Waters also recently made the following trade(s):
- On Friday, August 2nd, Michael Willem Waters sold 6,053 shares of Teladoc Health stock. The stock was sold at an average price of $8.14, for a total transaction of $49,271.42.
Teladoc Health Trading Down 2.1 %
Shares of TDOC stock opened at $7.51 on Friday. The stock has a 50 day simple moving average of $8.25 and a 200-day simple moving average of $11.43. Teladoc Health, Inc. has a 1-year low of $6.76 and a 1-year high of $22.98. The company has a market cap of $1.29 billion, a price-to-earnings ratio of -5.33 and a beta of 0.90. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.62.
Analyst Ratings Changes
Several equities analysts recently issued reports on TDOC shares. Bank of America cut their target price on Teladoc Health from $16.50 to $13.50 and set a “neutral” rating on the stock in a research report on Tuesday, May 14th. Canaccord Genuity Group reduced their price objective on Teladoc Health from $25.00 to $17.00 and set a “buy” rating for the company in a research note on Thursday, August 1st. Evercore ISI cut their price target on shares of Teladoc Health from $14.00 to $10.00 and set an “in-line” rating on the stock in a report on Tuesday, July 9th. Barclays reduced their price target on shares of Teladoc Health from $20.00 to $10.00 and set an “overweight” rating for the company in a research report on Thursday, August 1st. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Teladoc Health from $16.00 to $9.00 and set a “neutral” rating on the stock in a report on Monday, August 26th. Fourteen research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $12.44.
Get Our Latest Analysis on TDOC
Institutional Investors Weigh In On Teladoc Health
Several large investors have recently bought and sold shares of TDOC. ICA Group Wealth Management LLC purchased a new stake in shares of Teladoc Health during the fourth quarter worth approximately $28,000. Principal Securities Inc. purchased a new position in shares of Teladoc Health in the fourth quarter worth about $45,000. Signaturefd LLC boosted its position in Teladoc Health by 148.7% during the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after acquiring an additional 1,715 shares during the last quarter. International Assets Investment Management LLC acquired a new stake in Teladoc Health in the 2nd quarter valued at about $29,000. Finally, SageView Advisory Group LLC purchased a new position in Teladoc Health in the 1st quarter worth approximately $48,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
See Also
- Five stocks we like better than Teladoc Health
- How to Invest in the Best Canadian Stocks
- Fed Rate Cuts on the Horizon: Why These 2 Stocks Stand to Benefit
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- MarketBeat Week in Review – 9/2 – 9/6
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.